Precision medicine in multiple myeloma: are we there yet?

被引：5
|
作者：
Auclair, Daniel [1 ]
Lonial, Sagar [2 ]
Anderson, Kenneth C. [3 ]
Kumar, Shaji K. [4 ]
机构：
[1] Multiple Myeloma Res Fdn, Norwalk, CT USA
[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[4] Mayo Clin, Canc Ctr, Div Hematol, Rochester, MN USA
来源：
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | 2019年 / 4卷 / 02期
关键词：
THERAPIES;
D O I：
10.1080/23808993.2019.1578172
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 53
页数：3
相关论文
共 50 条
  • [41] Precision Genetic and Genomic Medicine in the Middle East and North Africa Region: Are We There Yet?
    Bilani, Nadeem
    Dagher, Michael
    Zgheib, Nathalie K.
    PUBLIC HEALTH GENOMICS, 2017, 20 (03) : 149 - 157
  • [42] Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
    Lagana, Alessandro
    Beno, Itai
    Melnekoff, David
    Leshchenko, Violetta
    Madduri, Deepu
    Ramdas, Dennis
    Sanchez, Larysa
    Niglio, Scot
    Perumal, Deepak
    Kidd, Brian A.
    Miotto, Riccardo
    Shaknovich, Rita
    Chari, Ajai
    Cho, Hearn Jay
    Barlogie, Bart
    Jagannath, Sundar
    Dudley, Joel T.
    Parekh, Samir
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 17
  • [43] Proteomics-inspired precision medicine for treating and understanding multiple myeloma
    Ho, Matthew
    Bianchi, Giada
    Anderson, Kenneth C.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (02): : 67 - 85
  • [44] Precision medicine: are we there?
    Winship, Ingrid
    MEDICAL JOURNAL OF AUSTRALIA, 2015, 203 (03) : 132 - +
  • [45] Minimal Residual Disease in Myeloma: Are We There Yet?
    Hart, Andrew J.
    Jagasia, Madan H.
    Kim, Annette S.
    Mosse, Claudio A.
    Savani, Bipin N.
    Kassim, Adetola
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1790 - 1799
  • [46] Cell lines of hyperdiploid myeloma, are we there yet?
    Chng, Wee J.
    Fonseca, Rafael
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (05) : 579 - 580
  • [47] Personalized Cancer Medicine: Are We There Yet?
    Lawler, Mark
    Selby, Peter
    ONCOLOGIST, 2013, 18 (06): : 649 - 650
  • [48] Personalized medicine for asthma: Are we there yet
    Poon, Audrey H.
    Hamid, Qutayba
    ANNALS OF THORACIC MEDICINE, 2012, 7 (02) : 55 - 56
  • [49] Towards personalized medicine—are we there yet?
    Jan Oldenburg
    Sophie D. Fosså
    Nature Reviews Urology, 2014, 11 : 68 - 69
  • [50] Regenerative Medicine for Stroke - Are We There Yet?
    Onteniente, Brigitte
    Polentes, Jerome
    CEREBROVASCULAR DISEASES, 2011, 31 (06) : 544 - 551
12345